Comment on Sanofi-Aventis says cancer drug has little effect

Sanofi-Aventis says cancer drug has little effect

French drugmaker Sanofi-Aventis SA said Thursday a clinical trial showed its drug candidate iniparib did not improve survival or slow disease progression in patients with breast cancer.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News